Table 2 Table of baseline information of CDKN2A high and low expression groups constructed based on TCGA database
Characteristics | Low expression of CDKN2A | High expression of CDKN2A | P value |
|---|---|---|---|
n | 269 | 270 | |
Pathologic T stage, n (%) | 0.806 | ||
T1 | 84 (15.7%) | 92 (17.2%) | |
T2 | 148 (27.6%) | 144 (26.9%) | |
T3 | 27 (5%) | 22 (4.1%) | |
T4 | 9 (1.7%) | 10 (1.9%) | |
Pathologic N stage, n (%) | 0.921 | ||
N0 | 174 (33.3%) | 176 (33.7%) | |
N1 | 48 (9.2%) | 49 (9.4%) | |
N2 | 40 (7.6%) | 34 (6.5%) | |
N3 | 1 (0.2%) | 1 (0.2%) | |
Age, median (IQR) | 65 (58, 72) | 67 (59, 73) | 0.113 |
Gender, n (%) | 0.831 | ||
Female | 143 (26.5%) | 146 (27.1%) | |
Male | 126 (23.4%) | 124 (23%) | |
Pathologic stage, n (%) | 0.433 | ||
I 期 | 141 (26.6%) | 155 (29.2%) | |
II 期 | 67 (12.6%) | 58 (10.9%) | |
III 期 | 41 (7.7%) | 43 (8.1%) | |
IV 期 | 16 (3%) | 10 (1.9%) |